Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,223 public trials 1,013 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Study of DF6215 in Patients With Advanced Solid Tumors

NCT06108479

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +42 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 21 locations
View Trial Details
Completed

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

NCT02973789

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Ironwood Cancer & Research Center Chandler, Arizona, United States
  • Cancer Center at St. Joseph Hospital and Medical Center Phoenix, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
View all 124 locations
View Trial Details
Completed

A Study of DF6002 Alone and in Combination With Nivolumab

NCT04423029

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • University of California Irvine Orange, California, United States
  • SCRI - HealthOne Denver Denver, Colorado, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
View all 32 locations
View Trial Details
Completed

Neoadjuvant Pembrolizumab

NCT02818920

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

NCT06894771

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +45 more
Locations
  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0301) Hackensack, New Jersey, United States
  • NEXT Oncology ( Site 0300) San Antonio, Texas, United States
  • Princess Margaret Cancer Center ( Site 0101) Toronto, Ontario, Canada
  • Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0102) Québec, Quebec, Canada
View Trial Details
Completed

Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer

NCT06525246

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • National Hospital Organization Shikoku Cancer Center Matsuyama, Ehime, Japan
  • Kobe City Medical Center General Hospital Kobe, Hyōgo, Japan
  • Hyogo College Of Medicine College Hospital Nishinomiya, Hyōgo, Japan
  • Kitasato University Hospital Sagamihara-shi, Kanagawa, Japan
View all 13 locations
View Trial Details

Related conditions